Peter Hall
@PeterHall001
Followers
771
Following
1K
Media
18
Statuses
2K
Oncologist interested in Data Science and Health Economics. Find me on https://t.co/1DqiYxPchS
Edinburgh, Scotland
Joined November 2009
Variation in chemotherapy prescribing rates and mortality in early breast cancer in Scotland. A national data linkage study - variation is reducing over the last 20 yrs @CancerDataEdin
1
1
6
RT @drdkulkarni: Edinburgh Breast Cancer Specialist Symposium 2025 (EBCSS) 21-22 Feb was a great success. Excellent scientific programme, e….
0
3
0
Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and older in the UK (Mammo-50): a multicentre, randomised, phase 3, non-inferiority trial - The Lancet
thelancet.com
For patients aged 50 years or older and at 3 years post diagnosis, less frequent mammograms were non-inferior compared with annual mammograms for breast cancer-specific survival, recurrence-free...
0
0
0
#SABCS24.FDA session highlighting need to consider Minimum Effictive Dose, not just Maximum Tolerated Dose. Reminds me of the GO2 trial last decade. Breast cancer drug development catching up?
jamanetwork.com
This randomized clinical trial assesses the efficacy of reduced-intensity chemotherapy for patient quality of life and cancer control in the treatment of older and/or frail patients.
0
0
0
RCT of the effect of the omega-3 polyunsaturated fatty acid EPA on colorectal cancer recurrence and survival after surgery for resectable liver metastases: EPA for Metastasis Trial 2 (EMT2) study protocol
bmjopen.bmj.com
Introduction There remains an unmet need for safe and cost-effective adjunctive treatment of advanced colorectal cancer (CRC). The omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) is...
0
0
0
Edinburgh Pain Assessment Tool EPAT results in prescription of less opioids but more adjuvant analgesics and non-pharmacological approaches. Reduces costs overall.
1
3
5
RT @drdkulkarni: Excellent EBCSS 2023 meeting yesterday. Most well organised meeting with the best programme. Heartiest congratulations to….
0
7
0
RT @KarinPurshouse: Great to see this out. First data from the SCCAMP study - we looked at COVID infection and vaccination status of patien….
academic.oup.com
This article characterizes the incidence and outcomes of SARS-CoV-2 infection and vaccination in patients with solid tumors undergoing anti-cancer treatmen
0
7
0
RT @KarinPurshouse: Check it out! 👆👆👆Real world ongoing study that we are excited to build upon. Truly collaborative, supported by @EdinCRC….
0
1
0
RT @fiekefroeling: If interested in #PancreaticCancer, #AI and #DataScience, please apply to join our team @precisionpanc @UofGCancerSci @C….
findaphd.com
PhD Project - FULLY FUNDED PROJECT - Identifying the histomorphological features and molecular drivers of pancreatic cancer progression at University of Glasgow, listed on FindAPhD.com
0
9
0
Real-World Impact of SABR on Stage I Non-Small-Cell Lung Cancer Outcomes at a Scottish Cancer Centre #mdpicancers via @Cancers_MDPI.
mdpi.com
Introduction: Stereotactic ablative body radiotherapy (SABR) offers patients with stage I non-small-cell lung cancer (NSCLC) a safe, effective radical therapy option. The impact of introducing SABR...
0
0
1
RT @EdinCRC: “The Scottish COVID Cancer Immunity Prevalence Study: A Longitudinal Study of SARS-CoV-2 Immune Response in Patients Receiving….
academic.oup.com
This article characterizes the incidence and outcomes of SARS-CoV-2 infection and vaccination in patients with solid tumors undergoing anti-cancer treatmen
0
5
0
RT @livvyswann: The protocol for our @HDR_UK project "Studying the Long term Impact of COVID in Kids" (SLICK) is now out in @BMJ_Open . Bri….
0
16
0
Reproductive history differs by molecular subtypes of breast cancer among women aged ≤ 50 years in Scotland diagnosed 2009–2016: a cross-sectional study.
link.springer.com
Breast Cancer Research and Treatment - The aetiology of breast cancers diagnosed ≤ 50 years of age remains unclear. We aimed to compare reproductive risk factors between...
0
1
1
RT @EdinHealthEcon: Look out for us at Scottish Health Economics! @PeterHall001 @ElizabethLemm @bullen_ali & our fresh faced new starter Ma….
0
3
0
RT @CRUKScotland: Exciting to see scientists from the Glasgow Beatson Institute joining fellow Cancer Research UK colleagues in Edinburgh a….
0
20
0
RT @data_can_hub: DATA-CAN partner organisations NHS Lothian and the University of Edinburgh have developed DataLoch, a new secure and pion….
data-can.org.uk
DATA-CAN partner organisations NHS Lothian and the University of Edinburgh have developed DataLoch, a new secure and pioneering data service which will enable improvements in health and social care...
0
3
0